Free Access
Vet. Res.
Volume 39, Number 3, May-June 2008
Number of page(s) 14
Published online 07 February 2008
How to cite this article Vet. Res. (2008) 39:21
References of  Vet. Res. (2008) 39:21
  1. Boehm U., Klamp T., Groot M., Howard J.C., Cellular responses to interferon-gamma, Annu. Rev. Immunol. (1997) 15:749-795 [CrossRef] [PubMed].
  2. Bungener L., Huckriede A., Wilschut J., Daemen T., Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs, Biosci. Rep. (2002) 22: 323-338.
  3. Cox J.C., Sjolander A., Barr I.G., ISCOMs and other saponin based adjuvants, Adv. Drug Deliv. Rev. (1998) 32:247-271 [CrossRef] [PubMed].
  4. Crouch C.F., Daly J., Hannant D., Wilkins J., Francis M.J., Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an "American lineage" H3N8 virus, Vaccine (2004) 23:418-425 [CrossRef] [PubMed].
  5. Crouch C.F., Daly J., Henley W., Hannant D., Wilkins J., Francis M.J., The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses, Vet. Immunol. Immunopathol. (2005) 108:345-355 [CrossRef] [PubMed].
  6. Daly J.M., Newton J.R., Mumford J.A., Current perspectives on control of equine influenza, Vet. Res. (2004) 35:411-423 [CrossRef] [PubMed] [EDP Sciences].
  7. Edlund Toulemonde C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M., Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom, Vet. Rec. (2005) 156:367-371 [PubMed].
  8. Gotch F., McMichael A., Smith G., Moss B., Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes, J. Exp. Med. (1987) 165:408-416 [CrossRef] [PubMed].
  9. Hannant D., Immunology of horses and donkeys, in: Handbook of vertebrate immunology, Pastoret P.P., Griebel P., Bazin H., Govaerts A. (Eds.), Academic Press, London, UK, 1998, pp. 343-371.
  10. Kienzle N., Buttigieg K., Groves P., Kawula T., Kelso A., A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression, J. Immunol. (2002) 168:1672-1681 [PubMed].
  11. Kienzle N., Olver S., Buttigieg K., Groves P., Janas M.L., Baz A., Kelso A., Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4, J. Immunol. (2005) 174:2021-2029 [PubMed].
  12. Madic J., Martinovic S., Naglic T., Hajsig D., Cvetnic S., Serological evidence for the presence of A/equine-1 influenza virus in unvaccinated horses in Croatia, Vet. Rec. (1996) 138:68 [PubMed].
  13. Morein B., Bengtsson K.L., Immunomodulation by iscoms, immune stimulating complexes, Methods (1999) 19:94-102 [CrossRef] [PubMed].
  14. Mumford J.A., Wood J., Establishing an acceptability threshold for equine influenza vaccines, Dev. Biol. Stand. (1992) 79:137-146 [PubMed].
  15. Mumford J.A., Jessett D.M., Rollinson E.A., Hannant D., Draper M.E., Duration of protective efficacy of equine influenza immunostimulating complex/ tetanus vaccines, Vet. Rec. (1994) 134:158-162 [PubMed].
  16. Mumford J.A., Jessett D.M., Dunleavy U., Wood J.L.N., Hannant D., Sundquist B., Cook R.F., Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines, Vaccine (1994) 12:857-863 [CrossRef] [PubMed].
  17. Newton J.R., Daly J.M., Spencer L., Mumford J.A., Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease, Vet. Rec. (2006) 158:185-192 [PubMed].
  18. Paillot R., Hannant D., Kydd J.H., Daly J.M., Vaccination against equine influenza: quid novi?, Vaccine (2006) 24:4047-4061 [CrossRef] [PubMed].
  19. Paillot R., Daly J., Juillard V., Minke J.M., Hannant D., Kydd J.H., Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1, Vaccine (2005) 23:4541-4551 [CrossRef] [PubMed].
  20. Paillot R., Kydd J.H., Macrae S., Minke J.M., Hannant D., Daly J.M., New assays to measure equine influenza virus-specific Type 1 immunity in horses, Vaccine (2007) 25:7385-7398 [CrossRef] [PubMed].
  21. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., Hannant D., Kydd J.H., Characterisation of CTL and IFN-g synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection, Vaccine (2006) 24:1490-1500 [CrossRef] [PubMed].
  22. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., Minke J.M., Daly J.M., Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus, Vet. Immunol. Immunopathol. (2006) 112:225-233 [CrossRef] [PubMed].
  23. Rimmelzwaan G.F., Nieuwkoop N., Brandenburg A., Sutter G., Beyer W.E., Maher D., Bates J., Osterhaus A.D., A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines, Vaccine (2000) 19:1180-1187 [CrossRef] [PubMed].
  24. Robson N.C., Beacock-Sharp H., Donachie A.M., Mowat A.M., The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes, Immunology (2003) 110:95-104 [CrossRef] [PubMed].
  25. Robson N.C., Beacock-Sharp H., Donachie A.M., Mowat A.M., Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading, Immunology (2003) 109:374-383 [CrossRef] [PubMed].
  26. Sambhara S., Kurichh A., Miranda R., Tamane A., Arpino R., James O., McGuinness U., Kandil A., Underdown B., Klein M., Burt D., Enhanced immune responses and resistance against infection in aged mice conferred by Flu-ISCOMs vaccine correlate with upregulation of costimulatory molecule CD86, Vaccine (1998) 16: 1698-1704.
  27. Sambhara S., Kurichh A., Miranda R., Tumpey T., Rowe T., Renshaw M., Arpino R., Tamane A., Kandil A., James O., Underdown B., Klein M., Katz J., Burt D., Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function, Cell. Immunol. (2001) 211: 143-153.
  28. Sanders M.T., Brown L.E., Deliyannis G., Pearse M.J., ISCOM-based vaccines: the second decade, Immunol. Cell. Biol. (2005) 83:119-128 [CrossRef] [PubMed].
  29. Sjolander A., van't Land B., Lovgren Bengtsson K., Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses, Cell. Immunol. (1997) 177:69-76 [CrossRef] [PubMed].
  30. Sjolander A., Cox J.C., Barr I.G., ISCOMs: an adjuvant with multiple functions J. Leukoc. Biol. (1998) 64:713-723.
  31. Sjolander A., Lovgren Bengtsson K., Johansson M., Morein B., Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins, Scand. J. Immunol. (1996) 43:164-172 [CrossRef] [PubMed].
  32. Sjolander S., Drane D., Davis R., Beezum L., Pearse M., Cox J., Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses, Vaccine (2001) 19:4072-4080 [CrossRef] [PubMed].
  33. Sundquist B., Lovgren K., Morein B., Influenza virus ISCOMs: antibody response in animals, Vaccine (1988) 6:49-53 [CrossRef] [PubMed].
  34. Trautmann A., Ruckert B., Schmid-Grendelmeier P., Niederer E., Brocker E.B., Blaser K., Akdis C.A., Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/ effector subpopulation, Immunology (2003) 108: 305-312.
  35. Viola A., Salio M., Tuosto L., Linkert S., Acuto O., Lanzavecchia A., Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering, J. Exp. Med. (1997) 186:1775-1779 [CrossRef] [PubMed].
  36. Wagner B., Hillegas J.M., Antczak D.F., A monoclonal antibody to equine interleukin-4, Vet. Immunol. Immunopathol. (2006) 110:363-367 [CrossRef] [PubMed].
  37. Watson D.L., Watson N.A., Fossum C., Lovgren K., Morein B., Interactions between immunestimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes, Microbiol. Immunol. (1992) 36:199-203 [PubMed].
  38. Wood J.M., Mumford J.A., Folkers C., Scott A.M., Schild G.C., Studies with inactivated equine influenza vaccine I. Serological responses of ponies to graded doses of vaccine, J. Hyg. (Lond.) (1983) 90:371-384 [PubMed].